Pfizer is focusing on India for future growth. The company plans to launch new medicines quickly and at affordable prices.

With fines for breaching consumer laws recently doubled to $100 million, the ACCC may soon be among Jim Chalmers’ favourite ...

Wednesday, May 13, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Meta ...

Pfizer has won expanded European Commission approval of its Hympavzi hemophilia drug for two patient populations. Pfizer on Wednesday said the green light covers patients ages 12 and older weighing at ...

But buying these types of contrarian stocks can also result in more significant gains later on, if the businesses are able to ...

The average patient-consumer, if willing to pay cash, may find some bargains. But getting the best deal could take some ...

Some vaccine companies have attractive prospects beyond any hantavirus-related work. An outbreak of the hantavirus on a ...

Stephen Chin, Vice President of Developer Relations at Neo4j, says the real threat is not AI itself but the growing skills ...

Entered into secured credit agreement with Innoviva for $25 million maturing in 2029 LOS ANGELES, May 13, 2026 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ...

Valneva presents its First Quarter 2026 Financial Results. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to your ...

A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.